Video file
Investing to Build Better Businesses
Healthcare

Carlyle’s Global Private Equity Healthcare investment team partners with healthcare providers, pharmaceutical products and services, diagnostics, payer services, medical products, healthcare technology, and digital health companies. Our team provides consistent support to strengthen healthcare companies’ businesses and lead global expansion, transforming local players into global product or service providers. 

0
+
total transactions
0
+
active portfolio companies
0
+
global investment professionals
$
0
BN+
total capital deployed

Sector Strategy and Approach

Our global Healthcare team is focused on investing behind key trends that ubiquitously impact healthcare delivery across global markets with an understanding that differentiators and disruptors can vary by region.

Working with the executive teams of our portfolio companies, Carlyle excels in driving performance through multiple levers of value creation, including international expansion, new product development, M&A, and strategic positioning strategies. Our investment strategy is underpinned by key themes that influence the global healthcare industry, including:

  • Growth in global healthcare demand driven by demographics, increased wealth, and a focus on public health.
  • Evolving regulatory environment shifting to address increased healthcare utilization, rising costs, and inequality in access.
  • Technology adoption and the incorporation of digital capabilities accelerating innovation in care delivery.
  • Evolution towards value-based care models driving increasing integration across healthcare systems.

We have developed a differentiated approach to finding businesses that are “part of the solution” in healthcare – whether through innovation, improving quality, reducing costs or improving the consumer experience. Our proprietary insights, diverse portfolio and deep global network position us to build better businesses in transformative ways.

Healthcare Portfolio Companies

Carlyle has a reputation as a partner of choice for world-class founders and management teams globally.

Abacus Pharmaceuticals

Industry
Healthcare
Invested
Status
Current
Read More

Abbisko

Industry
Healthcare
Invested
Status
Current
Read More

Acufocus, Inc.

Industry
Healthcare
Invested
Status
Current
Read More

Adicon Holdings Limited

Industry
Healthcare
Invested
Status
Current
Read More
Meet The Team

Global Healthcare Team

Our experienced global team is comprised of dedicated investment professionals based in New York, London, Paris, Munich, Tokyo, Mumbai, Hong Kong, Beijing, Shanghai and Sydney. We also consult with several Operating Executives and Senior Advisors who bring significant subject-matter expertise and relationships to Carlyle’s partnerships.

Managing Director
Mumbai, India
Managing Director
Sydney, Australia
Managing Director
New York, NY
Managing Director
London, UK
Managing Director
New York, NY
Managing Director
Munich, Germany
Managing Director
New York, NY
Managing Director
Tokyo, Japan
Better Businesses, Better Results
2021 Impact Review

Better Businesses, Better Results

The 2021 Impact Review highlights what better results look like, highlighting our comprehensive approach to driving impact within businesses, grounded in our long history of ESG integration.